Morgan Stanley Downgrades Cigna to Equal-Weight, Lowers Price Target to $238
Morgan Stanley analyst Ricky Goldwasser downgrades Cigna (NYSE:CI) from Overweight to Equal-Weight and lowers the price target from $255 to $238.
What 8 Analyst Ratings Have To Say About Cigna
Within the last quarter, Cigna (NYSE:CI) has observed the following analyst ratings:
Goldman Sachs Initiates Coverage On Cigna with Neutral Rating, Announces Price Target of $233
Goldman Sachs analyst Nathan Rice initiates coverage on Cigna (NYSE:CI) with a Neutral rating and announces Price Target of $233.
Bright Health Group Reports $750M Capital Raises
New financing from Cigna and long-term shareholder New Enterprise Associates affirms conviction in Bright Health Group's differentiated alignment model
MINNEAPOLIS--(BUSINESS WIRE)-- Bright Health Group, Inc.
Seaport Global Initiates Coverage On Cigna with Buy Rating, Announces Price Target of $270
Seaport Global analyst Joseph France initiates coverage on Cigna (NYSE:CI) with a Buy rating and announces Price Target of $270.
Morgan Stanley Maintains Overweight on Cigna, Lowers Price Target to $255
Morgan Stanley analyst Ricky Goldwasser maintains Cigna (NYSE:CI) with a Overweight and lowers the price target from $275 to $255.
BMO Capital Maintains Outperform on Cigna, Lowers Price Target to $275
BMO Capital analyst Matt Borsch maintains Cigna (NYSE:CI) with a Outperform and lowers the price target from $300 to $275.
Where Cigna Stands With Analysts
Cigna (NYSE:CI) has observed the following analyst ratings within the last quarter: